AcquisitionsApr 24, 2026, 06:07 AM
Bio Essence Acquires MediFlow AI Software for $3.5M in Stock
AI Summary
Bio Essence Corp. has entered into an Asset Purchase Agreement to acquire the MediFlow AI software, previously known as AcuVital, from Zhituo Software Co., Limited. This acquisition encompasses all associated software source code, system architecture, and data. In exchange, Zhituo will receive $3.5 million worth of Bio Essence common stock, with the final valuation and share count awaiting approval from the company's Board of Directors.
Key Highlights
- Bio Essence Corp. acquired MediFlow AI software from Zhituo Software Co., Limited.
- The acquisition includes all software source code, system architecture, and data.
- Compensation for the acquisition is $3,500,000 in Bio Essence common stock.
- The valuation and number of shares are subject to Board of Directors' approval.